Pfizer says its Paxlovid treatment is 89 per cent effective at preventing hospitalisation or death in at-risk Covid-19 patients. The drug is being manufactured at the multinational’s Ringaskiddy plant in Co Cork where 80 million courses are expected to be made by the end of the year. On Thursday, the European Medicines Agency recommended the antiviral pill be authorised for use in the EU.
Merck originally said its molnupiravir pill reduced the risk of hospitalisation and death among high-risk patients by 50 per cent but later revised this figure down to 30 per cent.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
England's stricter 'Plan B' Covid-19 measures expireAfter an uncomfortable but relatively brief return to coronavirus restrictions triggered by the Omicron variant, England is going back to 'Plan A' - learning to live with a disease that is probably here to stay. Endemic is not good! A clear, fact-based explainer of the reality of “living with Covid”:
Source: rtenews - 🏆 1. / 99 Read more »
Source: NewstalkFM - 🏆 19. / 55 Read more »